| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Denbaars Steven is a Director at PALX, with reported holdings spanning 3 companies. Recent filings cover 2 purchases and 10 sales. Those positions are worth an estimated $11.8M at current prices.
Our model assigns Denbaars Steven a below-average insider score of 43/100, based on 4 past trades. On a 3-month view, 50.0% of the rated trades came out ahead, averaging -12.9% over three months.
Denbaars Steven's largest disclosed position is in PALX as Director, worth about $7.0M. Net of sales, the recent Form 4 record there shows accumulation of 12,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | ALMU Aeluma, Inc. | Director | Sell | 25,000 | $13.83 | $345,741.25 | -6.8% | - | - | |
| Aug 27, 2026 | ALMU Aeluma, Inc. | Director | Sell10b5-1 | 25,000 | $13.83 | $345,741.25 | -6.8% | - | - | |
| May 20, 2026 | ALMU Aeluma, Inc. | Director | Sell10b5-1 | 25,000 | $20.23 | $505,630.23 | -6.3% | -23.3% | - | |
| Apr 20, 2026 | PALX Palomino Laboratories Inc. | Director | Buy | 12,500 | $4.00 | $50,000.00 | +0.7% | - | - | |
| Feb 26, 2026 | ALMU Aeluma, Inc. | Director | Sell10b5-1 | 25,000 | $16.71 | $417,860.00 | -6.1% | +45.2% | - | |
| Jun 22, 2021 | ALMU Aeluma, Inc. | Director | Buy | 100,000 | $2.00 | $200,000.00 | +36.1% | - | - |